|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online May 15, 2009
Journal of Experimental Biology 212, 1630-1637 (2009)
Published by The Company of Biologists 2009
doi: 10.1242/jeb.027375
Review Article |
Tethering, recycling and activation of the epithelial sodium–proton exchanger, NHE3
1 Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada,
T6G 2R7
2 Program in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada,
M5G 1X8
3 Department of Biochemistry, University of Toronto, Ontario, Canada
* Author for correspondence (e-mail: sga{at}sickkids.ca)
Accepted 6 January 2009
| Summary |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In addition to their key role in pH homeostasis, it has recently become
apparent that NHEs serve many other functions: they are instrumental to
Na+ (re)absorption in the renal and gastrointestinal tracts; they
play an important role in cell volume regulation, particularly in guarding
cells against shrinkage; they seem to be stringently required for
macropinocytosis; and they have been proposed to be involved in cell
migration. This functional versatility stems in part from the evolutionary
divergence of a primordial NHE into multiple isoforms with unique properties
and specialized functions (Brett et al.,
2005
; Orlowski and Grinstein,
2004
).
NHE isoforms
There are nine known NHE isoforms in the mammalian genome
(Brett et al., 2005
;
Orlowski and Grinstein, 2004
).
These can be grossly subdivided into two groups: those that reside and
function predominantly in the plasma membrane (NHE1–5) and those that
are found largely or exclusively in endomembrane organelles (NHE6–9).
The latter can in turn be subdivided into two separate phylogenetic clades:
NHE6, 7 and 9, which are related to the yeast NHX1 (sodium–proton
exchanger; non-mammalian) and reside in the endosomal/TGN (trans-Golgi
network) pathway; and NHE8 that has orthologues in Dictyostelium,
worms and flies, and in mammals is found both in endomembranes and on the
apical membrane of certain epithelia
(Brett et al., 2005
;
Orlowski and Grinstein, 2004
;
Slepkov et al., 2007
). In
addition, a distinct type of NHEs related to the bacterial NhaA and yeast NHA1
(sodium–proton antiporter) was recently identified also in the mammalian
genome (Brett et al., 2005
;
Xiang et al., 2007
). Like the
transporters of lower organisms, the mammalian paralogues NHA1 and NHA2 are
likely to be electrogenic (see below) and may have unique functions, although
remarkably little is known about them at present.
The plasmalemmal NHEs have varied tissue distribution and function. Some,
like the ubiquitously expressed NHE1, are restricted to the plasma membrane
and serve housekeeping functions such as pH homeostasis and cell volume
regulation (Bobulescu and Moe,
2006
; Fliegel,
2008
; Orlowski and Grinstein,
2007
; Slepkov et al.,
2007
). Others, like the apical epithelial isoform NHE3, can cycle
between the surface membrane and intracellular compartments and have highly
specialized functions including trans-epithelial Na+ transport and
systemic acid–base homeostasis
(Bobulescu and Moe, 2006
;
Donowitz and Li, 2007
). The
unique tissue distribution of NHE3 (detailed below) implicates it in critical
physiological processes like the control of systemic volume and pH. In
addition, its specific subcellular localization confers complexity to its
regulation, facilitating dynamic alterations in function. Because of its
distinguishing features and its functional importance we have chosen to make
NHE3 the focus of this review.
Tissue distribution
NHE3 is found almost exclusively in the epithelia of renal and
gastrointestinal tissue (Brant et al.,
1995
; Orlowski et al.,
1992
; Tse et al.,
1992
), although there is some suggestion that a low level of
expression also occurs in human thymus, prostate, testis and ovary
(Brant et al., 1995
). Renal
expression of NHE3 occurs in distinct segments of the nephron and is exclusive
to the luminal side of tubular epithelial cells
(Bobulescu et al., 2005a
).
Specifically, NHE3 is located in the proximal tubule and the thick descending
limb of the loop of Henle (Biemesderfer et
al., 1997
). Within the gastrointestinal tract, NHE3 is more widely
distributed. It can be found in epithelia from stomach, small intestine and
large intestine. It is found throughout all segments of the colon but its
expression is limited to the jejunum of the small intestine and the corpus and
antrum of the stomach (Orlowski et al.,
1992
; Tse et al.,
1992
).
NHE3 structure
NHE3 shares with the other NHE isoforms a bipartite structure: an
N-terminal, 12 pass transmembrane domain (residues 1–454 in the case of
NHE3), followed by a relatively unstructured cytosolic C-terminal domain
(residues 455–831) (Fig.
1). The transmembrane domain mediates ion exchange while the
cytosolic C-terminus regulates activity and interacts with the cytoskeleton
and other ancillary molecules. In contrast to most other isoforms, significant
empirical evidence exists to support this structure. The addition of epitopes
to NHE3 confirmed that the first loop, linking transmembrane helices 1 and 2,
is extracellular (Kurashima et al.,
1998
). A similar approach confirmed that the cytosolic C-terminus
is intracellular (Kurashima et al.,
1998
). Although this proposed structure for NHE3 is widely
accepted (Donowitz et al.,
2005
; Orlowski and Grinstein,
2004
; Weinman et al.,
2005
; Zachos et al.,
2005
), there is some conflicting evidence suggesting that epitopes
within the cytosolic C-terminus may be exposed to the extracellular milieu
(Biemesderfer et al., 1998
),
and a single in vitro analysis suggests that NHE3 may contain a
N-terminal signal sequence which is cleaved, leaving only 11 transmembrane
domains (Zizak et al.,
2000
).
|
Mutational analysis of, and comparisons to, NHE1 have implicated
transmembrane (TM) domains IV and VII of NHE3 in ion transport and TM domain
IX as the site of binding to amiloride analogues
(Orlowski and Kandasamy, 1996
;
Slepkov et al., 2005
).
Experiments utilizing chimeric and truncation mutants enabled the localization
of different regulatory domains within the C-terminus. These include sites
responsible for cAMP-mediated inhibition, a calcineurin homologous protein
(CHP)-binding site and regions responsible for phorbol ester and okadaic
acid-mediated inhibition (Cabado et al.,
1996
; Levine et al.,
1995
; Wakabayashi et al.,
1995
). Similarly, by mutating specific residues in the C-terminus
it was shown that both ezrin and NHERF-1/2 (sodium–hydrogen exchanger
regulatory factor) bind to this section of NHE3
(Cha et al., 2006
;
Weinman et al., 2003b
).
In contrast to NHE1 (Counillon et al.,
1994
), NHE3 is generally thought not to be glycosylated in most
systems (Orlowski and Grinstein,
2004
). Rabbit renal brush border membranes and porcine LLCPK cells
appear to be exceptions, because experiments utilizing inhibitors of
glycosylation in combination with SDS-PAGE analysis suggested that, in these
systems, NHE3 is glycosylated. Moreover, in these studies inhibition of
glycosylation prevented the apical expression of NHE3
(Bizal et al., 1996
;
Soleimani et al., 1996
).
Canine, rat, human and opossum NHE3, which are seemingly not glycosylated,
must possess other apical targeting motifs
(Bizal et al., 1996
;
Durkan et al., 2007
). Finally,
as with NHE1 (Fuster et al.,
2008
; Hisamitsu et al.,
2006
; Hisamitsu et al.,
2004
), the functional unit of NHE3 in the apical plasma membrane
is likely to be a homodimer or possibly a higher order oligomer
(Fafournoux et al., 1994
).
Function
NHE3 mediates the exchange of extracellular Na+ for
intracellular H+ with a stoichiometry of 1:1. Sodium–proton
exchange through NHE3 is therefore electroneutral. The driving force of this
cross-membrane exchange is the large inward gradient of Na+
generated by the Na+/K+-ATPase. Consequently the
exchanger is secondarily active. NHE3 is capable of functioning in reverse
(exchanging intracellular Na+ for extracellular H+) if
the chemical gradients are inverted
(Alexander et al., 2007
;
Wakabayashi et al., 2003
).
Studies where the extracellular concentration of Na+ was varied
revealed a Hill coefficient
1, suggesting a single extracellular
Na+-binding site (Levine et
al., 1993
). NHE3 preferentially exchanges Na+ for
H+, although extracellular lithium and H+ will compete
for the Na+-binding site at comparatively high concentrations.
Kinetic analysis of cytosolic H+ binding revealed a more complex
picture (Levine et al., 1993
).
The Hill coefficient with respect to internal H+ is approximately
2, indicating cooperativity in the activation of NHE3 by H+. Based
on this and other observations, the existence of two intracellular
H+-binding sites has been postulated: one is presumably the
substrate or H+-transport site whereas the other is an allosteric
modifier site that dictates the `set point' at which the exchanger becomes
acutely activated. Above the set point Na+/H+ exchange
is downregulated, preventing excessive alkalinization of the cytosol.
Mutational analysis suggested that the allosteric modifier activity depends on
two histidine residues in the juxta-membrane region of the cytosolic
C-terminus of the exchanger (Cha et al.,
2003
).
Hormonal regulation
Several hormones modulate the activity of NHE3. The best-described
mechanism involves parathyroid hormone (PTH)
(Azarani et al., 1995
;
Azarani et al., 1996
).
Engagement of the PTH receptor raises intracellular cAMP levels thereby
activating protein kinase A (PKA), which phosphorylates NHE3 at serines 552
and 605, a mechanism dependent on both ezrin and the NHERF (see below). This
ultimately leads to inhibition of NHE3 activity
(Collazo et al., 2000
).
Dopamine also inhibits NHE3 activity. Engagement of the dopaminergic receptor
in the proximal tubule activates PKA- and protein kinase C (PKC)-dependent
pathways, both of which are thought to be necessary for the endocytosis of
NHE3 and the consequent decrease in its activity
(Bacic et al., 2003
;
Gomes and Soares-da-Silva,
2004
; Hu et al.,
2001
; Pedrosa et al.,
2004
; Wiederkehr et al.,
2001
).
By contrast, NHE3 activity is increased by angiotensin II
(Dixit et al., 2004
;
Xu et al., 2006
). This occurs
through a redistribution of NHE3 to the plasma membrane; a process that is
dependent on c-Src (Tsuganezawa et al.,
1998
), phosphatidylinositol 3-kinase
(du Cheyron et al., 2003
) and
an increased synthesis of the exchanger
(Xu et al., 2006
).
Glucocorticoids also increase NHE3 activity. Acutely, a direct phosphorylation
of the cytosolic C-terminus of NHE3 by serum and glucocorticoid kinase (SGK)
at serine 663 causes the redistribution of NHE3 from endomembranes to the
apical membrane (Wang et al.,
2005
; Yun, 2003
;
Yun et al., 2002
). More
chronic exposure to glucocorticoid leads to an increased overall expression of
the exchanger (Ambuhl et al.,
1999
; Kandasamy and Orlowski,
1996
). Insulin increases NHE3 activity by similar means. Chronic
exposure to insulin increases surface expression of NHE3 via
SGK-catalyzed phosphorylation (Fuster et
al., 2006
). Finally, beta adrenergic stimulation (via
epinephrine or norepinephrine) also activates NHE3
(Hall et al., 1998
).
Role in mammalian physiology
NHE3 plays a critical role in salt (re)absorption, in the maintenance of
intravascular volume and in pH homeostasis
(Alexander and Grinstein, 2006
;
Bobulescu and Moe, 2006
).
Accordingly, NHE3-null mice display a decreased blood pressure, diarrhea and
an acidic plasma pH (Schultheis et al.,
1998
). These combined effects result in volume contraction, as
evinced by the severely elevated plasma rennin and angiotensin levels found in
these animals (Schultheis et al.,
1998
). The diarrhea is secondary to an increased osmotic load in
the lumen of the intestine and provides direct evidence for the important role
that NHE3 plays in Na+ absorption. Interestingly, decreased NHE3
expression caused by inflammatory cytokines appears to induce diarrhea in
inflammatory bowel diseases (Clayburgh et
al., 2006
; Sullivan et al., 2008). The importance of NHE3 to renal
Na+ and bicarbonate absorption was similarly demonstrated. Both
microperfusion and micropuncture studies on NHE3-null mice revealed a dramatic
decrease (
50%) in proximal tubular Na+ and bicarbonate
absorption (Lorenz et al.,
1999
; Wang et al.,
1999
). If not for a significant reduction in their glomerular
filtration rate and increased distal Na+ absorption, these mice
would not be viable (Lorenz et al.,
1999
; Schnermann,
1999
).
The movement of Na+ across the apical membrane creates a slight
but significant osmotic gradient that is responsible for the osmotically
driven flux of water (approximately 120 l day–1)
(Lorenz et al., 1999
). NHE3
should therefore also contribute to the passive paracellular flux of other
ions – such as calcium and magnesium – from the lumen of the
proximal tubule. NHE3 plays a further role in acid–base homeostasis by
indirectly facilitating the proximal tubular absorption of citrate as well as
the luminal retention of ammonium
(Bobulescu and Moe, 2008
;
Brennan et al., 1988
;
Nagami, 1988
). Finally, the
exchanger has also been implicated in the absorption of filtered proteins from
the proximal tubular lumen (Gekle et al.,
2004
), probably through a physical interaction with megalin
(Biemesderfer et al.,
1999
).
| Regulation of the distribution of NHE3 at the apical membrane |
|---|
|
|
|---|
|
Cytoskeletal tethering
Ultimately, the balance between exocytosis and endocytosis dictates the
apical expression level of NHE3. The rate of endocytosis, in turn, depends on
the number of exchangers that are available for internalization at the
membrane. In this regard, it is important to appreciate that not all the
plasmalemmal exchangers are equally susceptible to endocytosis. Only those
that can diffuse in the membrane to enter clathrin-coated pits can be
internalized whereas those that are immobile cannot. Indeed, a sizable
sub-population of the apical NHE3 appear to be tethered to the cytoskeleton,
which results in restricted motion and the inability to be engaged by the
endocytic machinery. As a result, the cytoskeleton can regulate NHE3
availability and activity. In support of this notion, perturbations of actin
(either through pharmacological inhibitors or genetic manipulation of the
small Rho-GTPases) were found to inhibit NHE3 activity
(Kurashima et al., 1999
;
Szaszi et al., 2000
). More
recent studies confirmed that an intact actin cytoskeleton is necessary for
optimal NHE3 activity. Manipulation of microvillar actin architecture through
the use of Clostridium difficile toxin B, inhibited NHE3 activity and
redistributed the apical exchangers to an endomembrane compartment
(Alexander et al., 2005
;
Hayashi et al., 2004
). The
best evidence that the actin cytoskeleton retains NHE3 in the apical membrane
was provided by measuring the lateral mobility of the exchangers in the plane
of the membrane. Determinations of fluorescence recovery after photobleaching
(FRAP) demonstrated that NHE3 is largely immobile in the apical plasma
membrane of epithelia (Alexander et al.,
2005
; Cha et al.,
2004
). The first study by Cha and colleagues used an NHE3
construct tagged with green fluorescent protein (GFP) at its extreme cytosolic
C-terminus and found that greater than 50% of the exchangers were immobile in
the plane of the membrane (Cha et al.,
2004
). These studies were limited by the fact that fluorescence
from GFP-tagged NHE3 in sub-apical endosomes could not be resolved from the
plasmalemmal exchangers. Furthermore, the attachment of a GFP moiety to the
C-terminus of the exchanger, the domain thought to be responsible for
tethering NHE3 to the cytoskeleton, may have altered its behavior. Instead of
GFP, the second study utilized NHE3 that was tagged by an extracellular
epitope, three tandem HA motifs (Alexander
et al., 2005
). By reacting the exofacial epitopes with antibodies
added extracellularly, we were able to detect exclusively those exchangers
located on the apical plasma membrane. Fab fragments were used for
immunolabeling to preclude cross-linking of the exchangers, which might have
altered their mobility. Using this approach, we found that 70% of apically
expressed NHE3 was immobile. Further investigation concluded that this
immobility was not the result of association of the exchangers with lipid
rafts. Instead, the reduced rate of recovery after photobleaching was
attributed to association with the cytoskeleton, because the mobile fraction
of the exchanger increased markedly when the actin filaments were perturbed.
Taken together, these results support the concept that NHE3 is localized to
the apical plasma membrane, at least in part, through a physical retention
mechanism mediated by the microvillar actin cytoskeleton.
Is NHE3 attached to the actin cytoskeleton by NHERF and ezrin?
Because attachment to the actin cytoskeleton contributes to the apical
retention of NHE3, potentially altering its activity, understanding the nature
of this interaction has become a research priority. Unexpected insights were
gained from studies designed to isolate the factor responsible for the
cAMP-mediated inhibition of NHE3, which led to the purification of the NHERF
(Weinman et al., 1993
).
Subsequent co-immunoprecipitation experiments revealed that NHERF and NHE3
interact directly in vivo. A PDZ domain in the C-terminus of NHERF-1
binds to the cytosolic tail of NHE3
(Weinman et al., 2003b
). As
NHE3 lacks a canonical PDZ-binding domain, the precise binding location is not
known, although the four carboxyl terminal amino acid residues, STHM, have
been implicated (Weinman et al.,
2003b
). Concurrently, NHERF was independently identified in a
screen for ezrin-binding partners and named ezrin-binding protein 50 (EBP50)
(Reczek et al., 1997
). A third
independent study demonstrated ezrin to bind to the regulatory subunit II of
protein kinase A (PKA RII)
(Dransfield et al., 1997
). The
fact that NHE3 needs to be associated with NHERF and ezrin to enable
cAMP-mediated inhibition was then confirmed by reconstituting the system
(Weinman et al., 2000b
).
These findings led to the generation of the current model of cAMP-mediated
inhibition of NHE3, which postulates that the exchanger associates with PKA
indirectly via NHERF and ezrin
(Donowitz et al., 2005
;
Minkoff et al., 1999
;
Weinman et al., 2005
;
Weinman et al., 2000a
;
Weinman et al., 2001
). When
activated, PKA phosphorylates NHE3 at serine residues 552 and 605
(Kurashima et al., 1997
;
Zhao et al., 1999
) mediating,
or at least facilitating, the inhibition of the exchanger
(Weinman et al., 2000b
).
Identification of a second NHERF isoform, NHE3 kinase A-regulatory protein
(E3KARP/NHERF-2), has provided further complexity to the proposed model. The
second isoform shares some of the functions described for NHERF-1, as it can
similarly mediate inhibition of NHE3 by cAMP
(Lamprecht et al., 1998
;
Yun et al., 1998
). It also
appears to be necessary for the Ca2+-mediated inhibition of NHE3
activity (Choi et al., 2004
;
Kim et al., 2002
;
Lee-Kwon et al., 2003
). A
third member of the NHERF family, NHERF-3/PDZK1, also physically interacts
with NHE3 in vitro and augments cAMP-mediated inhibition
(Cinar et al., 2007
;
Thomson et al., 2005
).
Ezrin not only binds to NHERF and PKA but is also known to associate with
actin via its C-terminal domain
(Niggli and Rossy, 2008
). It
has therefore been tacitly assumed that the same protein complex that controls
NHE3 phosphorylation also serves to anchor the exchangers to the cytoskeleton.
However, the hypothesis that NHE3 is attached to the apical actin skeleton
through NHERF and ezrin has never been directly tested and recent findings
call into question the validity of this model. First, the ezrin knockout mouse
does not display any of the phenotypic features that would be anticipated from
altered NHE3 activity caused by changes in its retention or regulation
(Saotome et al., 2004
;
Tamura et al., 2005
). Second,
NHE3 localization studies in these animals failed to show any redistribution
of the exchangers (Saotome et al.,
2004
). Of note, the phenotype of the NHERF-1 knockout animal is
also inconsistent with major relocalization of NHE3. These mice are
characterized by renal phosphate wasting and this phenotype appears also in
humans with NHERF-1 mutations (Karim et
al., 2008
). Similarly, while NHE3 lost susceptibility to
inhibition by cAMP in NHERF-1-null mice
(Cunningham et al., 2004
;
Murtazina et al., 2007
;
Weinman et al., 2003a
), the
localization of the exchangers was not noticeably altered in these animals
(Broere et al., 2008
;
Shenolikar et al., 2002
).
Third, recent studies reveal that ezrin can bind to NHE3 directly
(Cha and Donowitz, 2008
;
Cha et al., 2006
), calling
into question the need for NHERF-1 in an association between the actin
cytoskeleton and NHE3. Lastly, another PDZ adaptor protein, Shank2, appears to
alter NHE3 activity at least in part by regulating the cell surface expression
(Han et al., 2006
). Therefore,
the possibility that it may tether NHE3 to the actin cytoskeleton must also be
considered.
The preceding brief overview of the literature makes it clear that while the role of ezrin and NHERF isoforms in regulating the phosphorylation of NHE3 is well established, their participation in targeting and tethering the exchangers is less clear and requires additional study.
Localization to different plasma membrane domains
Not only are the exchangers segregated into surface and endomembrane
populations but evidence also exists to support the co-existence of at least
two different apical sub-populations of exchangers. Using a variety of
techniques including transmission electron microscopy, immunofluorescence
microscopy and gradient ultra-centrifugation, Biemesderfer and colleagues have
shown that NHE3 exists in at least two distinct sites within the apical plasma
membrane of the renal proximal tubule
(Biemesderfer et al., 1999
).
The first is an active population or more active population that resides along
the microvilli of the brush border and co-immunoprecipitates with dipeptidyl
peptidase IV (Girardi et al.,
2001
; Girardi et al.,
2004
). The second is a less active or possibly inactive population
that co-immunoprecipitates with megalin and is found in the regions between
microvilli, i.e. the inter-microvillar spaces
(Biemesderfer et al., 2001
).
Utilizing similar techniques, McDonough and colleagues provided evidence that
physiologically relevant stimuli such as a high salt diet or PTH
administration decrease proximal tubular sodium absorption and concomitantly
induce the redistribution of NHE3 from microvilli to the inter-microvillar
space (Yang et al., 2008
;
Zhang et al., 1999
).
Analysis of fluorescence recovery after photobleaching are consistent with
the idea that two separate populations of NHE3 co-exist on the apical
membrane. These studies provided evidence for a rapidly mobile fraction of
exchangers and a second, poorly mobile fraction
(Alexander et al., 2005
;
Cha et al., 2004
). Scanning
electron microscopy revealed that about 70% of the exchangers are associated
with microvilli whereas the remainder are scattered in the inter-microvillar
spaces. Remarkably, the fraction of microvilli-associated NHE3 is similar to
the fraction of immobile exchangers detected by photobleaching. These findings
suggest that the exchangers on the microvilli are tethered to the cytoskeleton
whereas those in the inter-microvillar space are free to diffuse
(Alexander et al., 2005
).
Another means of partitioning populations of NHE3 within the plasma
membrane may involve the association with lipid microdomains, often called
rafts. Using the criteria of detergent solubility and sedimentation pattern on
a sucrose gradient, Donowitz and coworkers inferred that NHE3 localizes to
lipid rafts (Li et al., 2001
).
In an epithelial cell culture model, they were able to show that disruption of
lipid rafts inhibited NHE3 activity, suggesting that the raft-associated
population was active (Murtazina et al.,
2006
). However, our fluorescence recovery studies failed to detect
changes in NHE3 mobility following disruption of rafts, implying that
partition into lipid microdomains is not the primary mechanism whereby NHE3 is
immobilized and retained in apical membranes
(Alexander et al., 2005
).
Instead it is possible that an interaction between NHE3 and membrane lipids
may control the activity of the exchangers. Accordingly, Fuster and colleagues
were able to demonstrate that polyphosphoinositides alter NHE3 activity,
although in their experiments, depletion of cholesterol failed to alter NHE3
activity (Fuster et al.,
2004
). Similarly, we were able to increase NHE3 activity by adding
a cone-shaped lipid, lysophosphatidyl choline, to the lipid bilayer
(Alexander et al., 2007
).
Jointly, these experiments point to a role of lipids in the control of NHE3
activity but whether lipids segregate the exchangers into sub-populations or
alter their lateral mobility is not obvious.
| Conclusions |
|---|
|
|
|---|
List of abbreviations
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Alexander, R. T. and Grinstein, S. (2006). Na+/H+ exchangers and the regulation of volume. Acta Physiol. (Oxf.) 187,159 -167.[CrossRef][Medline]
Alexander, R. T., Furuya, W., Szaszi, K., Orlowski, J. and
Grinstein, S. (2005). Rho GTPases dictate the mobility of the
Na/H exchanger NHE3 in epithelia: role in apical retention and targeting.
Proc. Natl. Acad. Sci. USA
102,12253
-12258.
Alexander, R. T., Malevanets, A., Durkan, A. M., Kocinsky, H.
S., Aronson, P. S., Orlowski, J. and Grinstein, S. (2007).
Membrane curvature alters the activation kinetics of the epithelial
Na+/H+ exchanger, NHE3. J. Biol.
Chem. 282,7376
-7384.
Ambuhl, P. M., Yang, X., Peng, Y., Preisig, P. A., Moe, O. W. and Alpern, R. J. (1999). Glucocorticoids enhance acid activation of the Na+/H+ exchanger 3 (NHE3). J. Clin. Invest. 103,429 -435.[Medline]
Azarani, A., Goltzman, D. and Orlowski, J.
(1995). Parathyroid hormone and parathyroid hormone-related
peptide inhibit the apical Na+/H+ exchanger NHE-3
isoform in renal cells (OK) via a dual signaling cascade involving
protein kinase A and C. J. Biol. Chem.
270,20004
-20010.
Azarani, A., Goltzman, D. and Orlowski, J.
(1996). Structurally diverse N-terminal peptides of parathyroid
hormone (PTH) and PTH-related peptide (PTHRP) inhibit the
Na+/H+ exchanger NHE3 isoform by binding to the
PTH/PTHRP receptor type I and activating distinct signaling pathways.
J. Biol. Chem. 271,14931
-14936.
Bacic, D., Kaissling, B., McLeroy, P., Zou, L., Baum, M. and Moe, O. W. (2003). Dopamine acutely decreases apical membrane Na/H exchanger NHE3 protein in mouse renal proximal tubule. Kidney Int. 64,2133 -2141.[CrossRef][Medline]
Biemesderfer, D., Rutherford, P. A., Nagy, T., Pizzonia, J. H., Abu-Alfa, A. K. and Aronson, P. S. (1997). Monoclonal antibodies for high-resolution localization of NHE3 in adult and neonatal rat kidney. Am. J. Physiol. 273,F289 -F299.[Medline]
Biemesderfer, D., DeGray, B. and Aronson, P. S.
(1998). Membrane topology of NHE3. Epitopes within the
carboxyl-terminal hydrophilic domain are exoplasmic. J. Biol.
Chem. 273,12391
-12396.
Biemesderfer, D., Nagy, T., DeGray, B. and Aronson, P. S.
(1999). Specific association of megalin and the
Na+/H+ exchanger isoform NHE3 in the proximal tubule.
J. Biol. Chem. 274,17518
-17524.
Biemesderfer, D., DeGray, B. and Aronson, P. S.
(2001). Active (9.6 s) and inactive (21 s) oligomers of NHE3 in
microdomains of the renal brush border. J. Biol. Chem.
276,10161
-10167.
Bizal, G. L., Howard, R. L., Bookstein, C., Rao, M. C., Chang, E. B. and Soleimani, M. (1996). Glycosylation of the Na+/H+ exchanger isoform NHE-3 is species specific. J. Lab. Clin. Med. 128,304 -312.[CrossRef][Medline]
Bobulescu, I. A. and Moe, O. W. (2006). Na+/H+ exchangers in renal regulation of acid–base balance. Semin. Nephrol. 26,334 -344.[CrossRef][Medline]
Bobulescu, I. A. and Moe, O. W. (2008). Luminal Na(+)/H (+) exchange in the proximal tubule. Pflugers Arch. 458,5 -21.[CrossRef][Medline]
Bobulescu, I. A., Di Sole, F. and Moe, O. W. (2005a). Na+/H+ exchangers: physiology and link to hypertension and organ ischemia. Curr. Opin. Nephrol. Hypertens. 14,485 -494.[Medline]
Bobulescu, I. A., Dwarakanath, V., Zou, L., Zhang, J., Baum, M.
and Moe, O. W. (2005b). Glucocorticoids acutely increase cell
surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3
exocytosis. Am. J. Physiol. Renal. Physiol.
289,F685
-F691.
Brant, S. R., Yun, C. H., Donowitz, M. and Tse, C. M. (1995). Cloning, tissue distribution, and functional analysis of the human Na+/N+ exchanger isoform, NHE3. Am. J. Physiol. 269,C198 -C206.[Medline]
Brennan, S., Hering-Smith, K. and Hamm, L. L. (1988). Effect of pH on citrate reabsorption in the proximal convoluted tubule. Am. J. Physiol. 255,F301 -F306.[Medline]
Brett, C. L., Donowitz, M. and Rao, R. (2005).
Evolutionary origins of eukaryotic sodium/proton exchangers. Am. J.
Physiol. Cell Physiol. 288,C223
-C239.
Broere, N., Chen, M., Cinar, A., Singh, A. K., Hillesheim, J., Riederer, B., Lunnemann, M., Rottinghaus, I., Krabbenhoft, A., Engelhardt, R. et al. (2008). Defective jejunal and colonic salt absorption and altered Na(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice. Pflugers Arch. 457,1079 -1091.[CrossRef][Medline]
Cabado, A. G., Yu, F. H., Kapus, A., Lukacs, G., Grinstein, S.
and Orlowski, J. (1996). Distinct structural domains confer
cAMP sensitivity and ATP dependence to the Na+/H+
exchanger NHE3 isoform. J. Biol. Chem.
271,3590
-3599.
Cha, B. and Donowitz, M. (2008). The epithelial brush border Na+/H+ exchanger NHE3 associates with the actin cytoskeleton by binding to ezrin directly and via PDZ domain-containing Na+/H+ exchanger regulatory factor (NHERF) proteins. Clin. Exp. Pharmacol. Physiol. 35,863 -871.[CrossRef][Medline]
Cha, B., Oh, S., Shanmugaratnam, J., Donowitz, M. and Yun, C. C. (2003). Two histidine residues in the juxta-membrane cytoplasmic domain of Na+/H+ exchanger isoform 3 (NHE3) determine the set point. J. Membr. Biol. 191, 49-58.[CrossRef][Medline]
Cha, B., Kenworthy, A., Murtazina, R. and Donowitz, M.
(2004). The lateral mobility of NHE3 on the apical membrane of
renal epithelial OK cells is limited by the PDZ domain proteins NHERF1/2, but
is dependent on an intact actin cytoskeleton as determined by FRAP.
J. Cell Sci. 117,3353
-3365.
Cha, B., Tse, M., Yun, C., Kovbasnjuk, O., Mohan, S., Hubbard,
A., Arpin, M. and Donowitz, M. (2006). The NHE3 juxtamembrane
cytoplasmic domain directly binds ezrin: dual role in NHE3 trafficking and
mobility in the brush border. Mol. Biol. Cell
17,2661
-2673.
Choi, J. W., Lee-Kwon, W., Jeon, E. S., Kang, Y. J., Kawano, K., Kim, H. S., Suh, P. G., Donowitz, M. and Kim, J. H. (2004). Lysophosphatidic acid induces exocytic trafficking of Na(+)/H(+) exchanger 3 by E3KARP-dependent activation of phospholipase C. Biochim. Biophys. Acta 1683,59 -68.[Medline]
Cinar, A., Chen, M., Riederer, B., Bachmann, O., Wiemann, M.,
Manns, M., Kocher, O. and Seidler, U. (2007). NHE3 inhibition
by cAMP and Ca2+ is abolished in PDZ-domain protein PDZK1-deficient
murine enterocytes. J. Physiol.
581,1235
-1246.
Clayburgh, D. R., Musch, M. W., Leitges, M., Fu, Y. X. and Turner, J. R. (2006). Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J. Clin. Invest. 116,2682 -2694.[CrossRef][Medline]
Collazo, R., Fan, L., Hu, M. C., Zhao, H., Wiederkehr, M. R. and
Moe, O. W. (2000). Acute regulation of
Na+/H+ exchanger NHE3 by parathyroid hormone
via NHE3 phosphorylation and dynamin-dependent endocytosis.
J. Biol. Chem. 275,31601
-31608.
Counillon, L., Pouyssegur, J. and Reithmeier, R. A. (1994). The Na+/H+ exchanger NHE-1 possesses N- and O-linked glycosylation restricted to the first N-terminal extracellular domain. Biochemistry 33,10463 -10469.[CrossRef][Medline]
Cunningham, R., Steplock, D., Wang, F., Huang, H. E. X.,
Shenolikar, S. and Weinman, E. J. (2004). Defective
parathyroid hormone regulation of NHE3 activity and phosphate adaptation in
cultured NHERF-1–/– renal proximal tubule cells.
J. Biol. Chem. 279,37815
-37821.
Dixit, M. P., Xu, L., Xu, H., Bai, L., Collins, J. F. and Ghishan, F. K. (2004). Effect of angiotensin-II on renal Na+/H+ exchanger-NHE3 and NHE2. Biochim Biophys Acta. 1664,38 -44.[Medline]
Donowitz, M. and Li, X. (2007). Regulatory
binding partners and complexes of NHE3. Physiol. Rev.
87,825
-872.
Donowitz, M., Cha, B., Zachos, N. C., Brett, C. L., Sharma, A.,
Tse, C. M. and Li, X. (2005). NHERF family and NHE3
regulation. J. Physiol.
567, 3-11.
Dransfield, D. T., Bradford, A. J., Smith, J., Martin, M., Roy, C., Mangeat, P. H. and Goldenring, J. R. (1997). Ezrin is a cyclic AMP-dependent protein kinase anchoring protein. EMBO J. 16,35 -43.[CrossRef][Medline]
D'Souza, S., Garcia-Cabado, A., Yu, F., Teter, K., Lukacs, G.,
Skorecki, K., Moore, H. P., Orlowski, J. and Grinstein, S.
(1998). The epithelial sodium-hydrogen antiporter
Na+/H+ exchanger 3 accumulates and is functional in
recycling endosomes. J. Biol. Chem.
273,2035
-2043.
du Cheyron, D., Chalumeau, C., Defontaine, N., Klein, C., Kellermann, O., Paillard, M. and Poggioli, J. (2003). Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase. Kidney Int. 64,939 -949.[CrossRef][Medline]
Durkan, A. M., Alexander, R. T., Liu, G. Y., Rui, M., Femia, G.
and Robinson, L. A. (2007). Expression and targeting of
CX3CL1 (Fractalkine) in renal tubular epithelial cells. J. Am. Soc.
Nephrol. 18,74
-83.
Fafournoux, P., Noel, J. and Pouyssegur, J.
(1994). Evidence that Na+/H+ exchanger
isoforms NHE1 and NHE3 exist as stable dimers in membranes with a high degree
of specificity for homodimers. J. Biol. Chem.
269,2589
-2596.
Fliegel, L. (2008). Molecular biology of the myocardial Na+/H+ exchanger. J. Mol. Cell Cardiol. 44,228 -237.[Medline]
Fuster, D., Moe, O. W. and Hilgemann, D. W.
(2004). Lipid- and mechanosensitivities of sodium/hydrogen
exchangers analyzed by electrical methods. Proc. Natl. Acad. Sci.
USA 101,10482
-10487.
Fuster, D. G., Bobulescu, I. A., Zhang, J., Wade, J. and Moe, O. W. (2006). Characterization of the Regulation of Renal Na+/H+ Exchanger NHE3 by Insulin. Am. J. Physiol. Renal Physiol. 292,F577 -F585.[CrossRef][Medline]
Fuster, D., Moe, O. W. and Hilgemann, D. W.
(2008). Steady-state function of the ubiquitous mammalian Na/H
exchanger (NHE1) in relation to dimer coupling models with 2Na/2H
stoichiometry. J. Gen. Physiol.
132,465
-480.
Gekle, M., Volker, K., Mildenberger, S., Freudinger, R., Shull,
G. E. and Wiemann, M. (2004). NHE3
Na+/H+ exchanger supports proximal tubular protein
reabsorption in vivo. Am. J. Physiol. Renal
Physiol. 287,F469
-F473.
Girardi, A. C., Degray, B. C., Nagy, T., Biemesderfer, D. and
Aronson, P. S. (2001). Association of Na(+)-H(+) exchanger
isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule.
J. Biol. Chem. 276,46671
-46677.
Girardi, A. C., Knauf, F., Demuth, H. U. and Aronson, P. S.
(2004). Role of dipeptidyl peptidase IV in regulating activity of
Na+/H+ exchanger isoform NHE3 in proximal tubule cells.
Am. J. Physiol. Cell Physiol.
287,C1238
-C1245.
Gomes, P. and Soares-da-Silva, P. (2004). Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades. Eur. J. Pharmacol. 488,51 -59.[CrossRef][Medline]
Hall, R. A., Premont, R. T., Chow, C. W., Blitzer, J. T., Pitcher, J. A., Claing, A., Stoffel, R. H., Barak, L. S., Shenolikar, S., Weinman, E. J. et al. (1998). The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 392,626 -630.[CrossRef][Medline]
Han, W., Kim, K. H., Jo, M. J., Lee, J. H., Yang, J., Doctor, R.
B., Moe, O. W., Lee, J., Kim, E. and Lee, M. G. (2006).
Shank2 associates with and regulates Na+/H+ exchanger 3.
J. Biol. Chem. 281,1461
-1469.
Hayashi, H., Szaszi, K., Coady-Osberg, N., Furuya, W.,
Bretscher, A. P., Orlowski, J. and Grinstein, S. (2004).
Inhibition and redistribution of NHE3, the apical Na+/H+
exchanger, by Clostridium difficile toxin B. J. Gen.
Physiol. 123,491
-504.
Hisamitsu, T., Pang, T., Shigekawa, M. and Wakabayashi, S. (2004). Dimeric interaction between the cytoplasmic domains of the Na+/H+ exchanger NHE1 revealed by symmetrical intermolecular cross-linking and selective co-immunoprecipitation. Biochemistry 43,11135 -11143.[CrossRef][Medline]
Hisamitsu, T., Ben Ammar, Y., Nakamura, T. Y. and Wakabayashi, S. (2006). Dimerization is crucial for the function of the Na+/H+ exchanger NHE1. Biochemistry 45,13346 -13355.[CrossRef][Medline]
Hryciw, D. H., Lee, E. M., Pollock, C. A. and Poronnik, P. (2004). Molecular changes in proximal tubule function in diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 31,372 -379.[CrossRef][Medline]
Hu, M. C., Fan, L., Crowder, L. A., Karim-Jimenez, Z., Murer, H.
and Moe, O. W. (2001). Dopamine acutely stimulates
Na+/H+ exchanger (NHE3) endocytosis via
clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3
phosphorylation. J. Biol. Chem.
276,26906
-26915.
Kandasamy, R. A. and Orlowski, J. (1996).
Genomic organization and glucocorticoid transcriptional activation of the rat
Na+/H+ exchanger Nhe3 gene. J. Biol.
Chem. 271,10551
-10559.
Karim, Z., Gerard, B., Bakouh, N., Alili, R., Leroy, C., Beck,
L., Silve, C., Planelles, G., Urena-Torres, P., Grandchamp, B. et al.
(2008). NHERF1 mutations and responsiveness of renal parathyroid
hormone. N. Engl. J. Med.
359,1128
-1135.
Kaunisto, K. M. and Rajaniemi, H. J. (2002). Expression and localization of the Na+/H+ exchanger isoform NHE3 in the rat efferent ducts. J. Androl. 23,237 -241.[Abstract]
Kim, J. H., Lee-Kwon, W., Park, J. B., Ryu, S. H., Yun, C. H.
and Donowitz, M. (2002). Ca(2+)-dependent inhibition of
Na+/H+ exchanger 3 (NHE3) requires an
NHE3-E3KARP-alpha-actinin-4 complex for oligomerization and endocytosis.
J. Biol. Chem. 277,23714
-23724.
Klisic, J., Zhang, J., Nief, V., Reyes, L., Moe, O. W. and
Ambuhl, P. M. (2003). Albumin regulates the
Na+/H+ exchanger 3 in OKP cells. J. Am. Soc.
Nephrol. 14,3008
-3016.
Kurashima, K., Yu, F. H., Cabado, A. G., Szabo, E. Z.,
Grinstein, S. and Orlowski, J. (1997). Identification of
sites required for down-regulation of Na+/H+ exchanger
NHE3 activity by cAMP-dependent protein kinase. phosphorylation-dependent and
- independent mechanisms. J. Biol. Chem.
272,28672
-28679.
Kurashima, K., Szabo, E. Z., Lukacs, G., Orlowski, J. and
Grinstein, S. (1998). Endosomal recycling of the
Na+/H+ exchanger NHE3 isoform is regulated by the
phosphatidylinositol 3-kinase pathway. J. Biol. Chem.
273,20828
-20836.
Kurashima, K., D'Souza, S., Szaszi, K., Ramjeesingh, R.,
Orlowski, J. and Grinstein, S. (1999). The apical Na(+)/H(+)
exchanger isoform NHE3 is regulated by the actin cytoskeleton. J.
Biol. Chem. 274,29843
-29849.
Lamprecht, G., Weinman, E. J. and Yun, C. H.
(1998). The role of NHERF and E3KARP in the cAMP-mediated
inhibition of NHE3. J. Biol. Chem.
273,29972
-29978.
Lee-Kwon, W., Kim, J. H., Choi, J. W., Kawano, K., Cha, B.,
Dartt, D. A., Zoukhri, D. and Donowitz, M. (2003).
Ca2+-dependent inhibition of NHE3 requires PKC alpha which binds to
E3KARP to decrease surface NHE3 containing plasma membrane complexes.
Am. J. Physiol. Cell Physiol.
285,C1527
-C1536.
Levine, S. A., Montrose, M. H., Tse, C. M. and Donowitz, M.
(1993). Kinetics and regulation of three cloned mammalian
Na+/H+ exchangers stably expressed in a fibroblast cell
line. J. Biol. Chem.
268,25527
-25535.
Levine, S. A., Nath, S. K., Yun, C. H., Yip, J. W., Montrose,
M., Donowitz, M. and Tse, C. M. (1995). Separate C-terminal
domains of the epithelial specific brush border Na+/H+
exchanger isoform NHE3 are involved in stimulation and inhibition by protein
kinases/growth factors. J. Biol. Chem.
270,13716
-13725.
Li, X., Galli, T., Leu, S., Wade, J. B., Weinman, E. J., Leung,
G., Cheong, A., Louvard, D. and Donowitz, M. (2001).
Na+-H+ exchanger 3 (NHE3) is present in lipid rafts in
the rabbit ileal brush border: a role for rafts in trafficking and rapid
stimulation of NHE3. J. Physiol.
537,537
-552.
Li, X., Zhang, H., Cheong, A., Leu, S., Chen, Y., Elowsky, C. G.
and Donowitz, M. (2004). Carbachol regulation of rabbit ileal
brush border Na+-H+ exchanger 3 (NHE3) occurs through
changes in NHE3 trafficking and complex formation and is Src dependent.
J. Physiol. 556,791
-804.
Lorenz, J. N., Schultheis, P. J., Traynor, T., Shull, G. E. and Schnermann, J. (1999). Micropuncture analysis of single-nephron function in NHE3-deficient mice. Am. J. Physiol. 277,F447 -F453.[Medline]
Malo, M. E. and Fliegel, L. (2006). Physiological role and regulation of the Na+/H+ exchanger. Can. J. Physiol. Pharmacol. 84,1081 -1095.[CrossRef][Medline]
Minkoff, C., Shenolikar, S. and Weinman, E. J. (1999). Assembly of signaling complexes by the sodium-hydrogen exchanger regulatory factor family of PDZ-containing proteins. Curr. Opin. Nephrol. Hypertens. 8, 603-608.[CrossRef][Medline]
Murtazina, R., Kovbasnjuk, O., Donowitz, M. and Li, X.
(2006). Na+/H+ exchanger NHE3 activity and
trafficking are lipid Raft-dependent. J. Biol. Chem.
281,17845
-17855.
Murtazina, R., Kovbasnjuk, O., Zachos, N. C., Li, X., Chen, Y.,
Hubbard, A., Hogema, B. M., Steplock, D., Seidler, U., Hoque, K. M. et al.
(2007). Tissue-specific regulation of sodium/proton exchanger
isoform 3 activity in Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) null
mice. cAMP inhibition is differentially dependent on NHERF1 and exchange
protein directly activated by cAMP in ileum versus proximal tubule.
J. Biol. Chem. 282,25141
-25151.
Nagami, G. T. (1988). Luminal secretion of ammonia in the mouse proximal tubule perfused in vitro. J. Clin. Invest. 81,159 -164.[Medline]
Niggli, V. and Rossy, J. (2008). Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical cytoskeleton. Int. J. Biochem. Cell Biol. 40,344 -349.[CrossRef][Medline]
Noel, J., Roux, D. and Pouyssegur, J. (1996). Differential localization of Na+/H+ exchanger isoforms (NHE1 and NHE3) in polarized epithelial cell lines. J. Cell Sci. 109,929 -939.[Abstract]
Orlowski, J. and Grinstein, S. (2004). Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch. 447,549 -565.[CrossRef][Medline]
Orlowski, J. and Grinstein, S. (2007). Emerging roles of alkali cation/proton exchangers in organellar homeostasis. Curr. Opin. Cell Biol. 19,483 -492.[CrossRef][Medline]
Orlowski, J. and Kandasamy, R. A. (1996).
Delineation of transmembrane domains of the Na+/H+
exchanger that confer sensitivity to pharmacological antagonists.
J. Biol. Chem. 271,19922
-19927.
Orlowski, J., Kandasamy, R. A. and Shull, G. E.
(1992). Molecular cloning of putative members of the Na/H
exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA
tissue expression of the rat Na/H exchanger NHE-1 and two structurally related
proteins. J. Biol. Chem.
267,9331
-9339.
Pedrosa, R., Gomes, P., Hopfer, U., Jose, P. A. and
Soares-da-Silva, P. (2004). Gialpha3 protein-coupled dopamine
D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular
cells is a PLC-PKC-mediated event. Am. J. Physiol. Renal
Physiol. 287,F1059
-F1066.
Pushkin, A., Clark, I., Kwon, T. H., Nielsen, S. and Kurtz, I. (2000). Immunolocalization of NBC3 and NHE3 in the rat epididymis: colocalization of NBC3 and the vacuolar H+-ATPase. J. Androl. 21,708 -720.[Abstract]
Reczek, D., Berryman, M. and Bretscher, A.
(1997). Identification of EBP50: A PDZ-containing phosphoprotein
that associates with members of the ezrin-radixin-moesin family. J.
Cell Biol. 139,169
-179.
Saotome, I., Curto, M. and McClatchey, A. I. (2004). Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev. Cell 6, 855-864.[CrossRef][Medline]
Schnermann, J. (1999). Micropuncture analysis
of tubuloglomerular feedback regulation in transgenic mice. J. Am.
Soc. Nephrol. 10,2614
-2619.
Schultheis, P. J., Clarke, L. L., Meneton, P., Miller, M. L., Soleimani, M., Gawenis, L. R., Riddle, T. M., Duffy, J. J., Doetschman, T., Wang, T. et al. (1998). Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat. Genet. 19,282 -285.[CrossRef][Medline]
Shenolikar, S., Voltz, J. W., Minkoff, C. M., Wade, J. B. and
Weinman, E. J. (2002). Targeted disruption of the mouse
NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate
cotransporter type IIa and renal phosphate wasting. Proc. Natl.
Acad. Sci. USA 99,11470
-11475.
Slepkov, E. R., Rainey, J. K., Li, X., Liu, Y., Cheng, F. J.,
Lindhout, D. A., Sykes, B. D. and Fliegel, L. (2005).
Structural and functional characterization of transmembrane segment IV of the
NHE1 isoform of the Na+/H+ exchanger. J.
Biol. Chem. 280,17863
-17872.
Slepkov, E. R., Rainey, J. K., Sykes, B. D. and Fliegel, L. (2007). Structural and functional analysis of the Na+/H+ exchanger. Biochem. J. 401,623 -633.[CrossRef][Medline]
Soleimani, M., Singh, G., Bookstein, C., Rao, M. C., Chang, E. B. and Dominguez, J. H. (1996). Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells. J. Lab. Clin. Med. 127,565 -573.[CrossRef][Medline]
Sullivan, S., Alex, P., Dassopoulos, T., Zachos, N. C., Iacobuzio-Donahue, C., Donowitz, M., Brant, S. R., Cuffari, C., Harris, M. L., Datta, L. W. et al. (2009). Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis. 15,261 -274.[CrossRef][Medline]
Szaszi, K., Kurashima, K., Kapus, A., Paulsen, A., Kaibuchi, K.,
Grinstein, S. and Orlowski, J. (2000). RhoA and rho kinase
regulate the epithelial Na+/H+ exchanger NHE3. Role of
myosin light chain phosphorylation. J. Biol. Chem.
275,28599
-28606.
Tamura, A., Kikuchi, S., Hata, M., Katsuno, T., Matsui, T.,
Hayashi, H., Suzuki, Y., Noda, T., Tsukita, S. and Tsukita, S.
(2005). Achlorhydria by ezrin knockdown: defects in the
formation/expansion of apical canaliculi in gastric parietal cells.
J. Cell Biol. 169,21
-28.
Thomson, R. B., Wang, T., Thomson, B. R., Tarrats, L., Girardi,
A., Mentone, S., Soleimani, M., Kocher, O. and Aronson, P. S.
(2005). Role of PDZK1 in membrane expression of renal brush
border ion exchangers. Proc. Natl. Acad. Sci. USA
102,13331
-13336.
Tse, C. M., Brant, S. R., Walker, M. S., Pouyssegur, J. and
Donowitz, M. (1992). Cloning and sequencing of a rabbit cDNA
encoding an intestinal and kidney-specific Na+/H+
exchanger isoform (NHE-3). J. Biol. Chem.
267,9340
-9346.
Tsuganezawa, H., Preisig, P. A. and Alpern, R. J. (1998). Dominant negative c-Src inhibits angiotensin II induced activation of NHE3 in OKP cells. Kidney Int. 54,394 -398.[CrossRef][Medline]
Wakabayashi, S., Ikeda, T., Noel, J., Schmitt, B., Orlowski, J.,
Pouyssegur, J. and Shigekawa, M. (1995). Cytoplasmic domain
of the ubiquitous Na+/H+ exchanger NHE1 can confer
Ca2+ responsiveness to the apical isoform NHE3. J. Biol.
Chem. 270,26460
-26465.
Wakabayashi, S., Hisamitsu, T., Pang, T. and Shigekawa, M.
(2003). Kinetic dissection of two distinct proton binding sites
in Na+/H+ exchangers by measurement of reverse mode
reaction. J. Biol. Chem.
278,43580
-43585.
Wang, D., Sun, H., Lang, F. and Yun, C. C.
(2005). Activation of NHE3 by dexamethasone requires
phosphorylation of NHE3 at Ser663 by SGK1. Am. J. Physiol. Cell
Physiol. 289,C802
-C810.
Wang, T., Yang, C. L., Abbiati, T., Schultheis, P. J., Shull, G. E., Giebisch, G. and Aronson, P. S. (1999). Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. Am. J. Physiol. 277,F298 -F302.[Medline]
Weinman, E. J., Steplock, D. and Shenolikar, S. (1993). CAMP-mediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor. J. Clin. Invest. 92,1781 -1786.[Medline]
Weinman, E. J., Minkoff, C. and Shenolikar, S.
(2000a). Signal complex regulation of renal transport proteins:
NHERF and regulation of NHE3 by PKA. Am. J. Physiol. Renal
Physiol. 279,F393
-F399.
Weinman, E. J., Steplock, D., Donowitz, M. and Shenolikar, S. (2000b). NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3. Biochemistry 39,6123 -6129.[CrossRef][Medline]
Weinman, E. J., Steplock, D. and Shenolikar, S. (2001). Acute regulation of NHE3 by protein kinase A requires a multiprotein signal complex. Kidney Int. 60,450 -454.[CrossRef][Medline]
Weinman, E. J., Steplock, D. and Shenolikar, S. (2003a). NHERF-1 uniquely transduces the cAMP signals that inhibit sodium-hydrogen exchange in mouse renal apical membranes. FEBS Lett. 536,141 -144.[CrossRef][Medline]
Weinman, E. J., Wang, Y., Wang, F., Greer, C., Steplock, D. and Shenolikar, S. (2003b). A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange. Biochemistry 42,12662 -12668.[CrossRef][Medline]
Weinman, E. J., Cunningham, R. and Shenolikar, S. (2005). NHERF and regulation of the renal sodium-hydrogen exchanger NHE3. Pflugers Arch. 450,137 -144.[CrossRef][Medline]
Wiederkehr, M. R., Di Sole, F., Collazo, R., Quinones, H., Fan, L., Murer, H., Helmle-Kolb, C. and Moe, O. W. (2001). Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells. Kidney Int. 59,197 -209.[Medline]
Xiang, M., Feng, M., Muend, S. and Rao, R.
(2007). A human Na+/H+ antiporter sharing
evolutionary origins with bacterial NhaA may be a candidate gene for essential
hypertension. Proc. Natl. Acad. Sci. USA
104,18677
-18681.
Xu, L., Dixit, M. P., Nullmeyer, K. D., Xu, H., Kiela, P. R., Lynch, R. M. and Ghishan, F. K. (2006). Regulation of Na+/H+ exchanger-NHE3 by angiotensin-II in OKP cells. Biochim Biophys Acta. 1758,519 -526.[Medline]
Yang, L. E., Sandberg, M. B., Can, A. D., Pihakaski-Maunsbach,
K. and McDonough, A. A. (2008). Effects of dietary salt on
renal Na+ transporter subcellular distribution, abundance, and
phosphorylation status. Am. J. Physiol. Renal Physiol.
295,F1003
-F1016.
Yun, C. C. (2003). Concerted roles of SGK1 and the Na+/H+ exchanger regulatory factor 2 (NHERF2) in regulation of NHE3. Cell Physiol. Biochem. 13, 29-40.[CrossRef][Medline]
Yun, C. C., Chen, Y. and Lang, F. (2002).
Glucocorticoid activation of Na(+)/H(+) exchanger isoform 3 revisited. The
roles of SGK1 and NHERF2. J. Biol. Chem.
277,7676
-7683.
Yun, C. H., Lamprecht, G., Forster, D. V. and Sidor, A.
(1998). NHE3 kinase A regulatory protein E3KARP binds the
epithelial brush border Na+/H+ exchanger NHE3 and the
cytoskeletal protein ezrin. J. Biol. Chem.
273,25856
-25863.
Zachos, N. C., Tse, M. and Donowitz, M. (2005). Molecular physiology of intestinal Na+/H+ exchange. Annu. Rev. Physiol. 67,411 -443.[CrossRef][Medline]
Zhang, Y., Norian, J. M., Magyar, C. E., Holstein-Rathlou, N. H., Mircheff, A. K. and McDonough, A. A. (1999). In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am. J. Physiol. 276,F711 -F719.[Medline]
Zhao, H., Wiederkehr, M. R., Fan, L., Collazo, R. L., Crowder,
L. A. and Moe, O. W. (1999). Acute inhibition of Na/H
exchanger NHE-3 by cAMP. Role of protein kinase a and NHE-3 phosphoserines 552
and 605. J. Biol. Chem.
274,3978
-3987.
Zhao, H., Shiue, H., Palkon, S., Wang, Y., Cullinan, P.,
Burkhardt, J. K., Musch, M. W., Chang, E. B. and Turner, J. R.
(2004). Ezrin regulates NHE3 translocation and activation after
Na+-glucose cotransport. Proc. Natl. Acad. Sci.
USA 101,9485
-9490.
Zizak, M., Cavet, M. E., Bayle, D., Tse, C. M., Hallen, S., Sachs, G. and Donowitz, M. (2000). Na(+)/H(+) exchanger NHE3 has 11 membrane spanning domains and a cleaved signal peptide: topology analysis using in vitro transcription/translation. Biochemistry 39,8102 -8112.[CrossRef][Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JEB:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||